SSSatoru Sugimoto

Satoru Sugimoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satoru Sugimoto has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Keisuke Sasai

    Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan

    4 shared publications
  • Hironori Nagata

    Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, Kamakura, Kanagawa, 247-8533, JAPAN

    3 shared publications
  • Tatsuya Inoue

    Juntendo University Urayasu Hospital, Department of Radiology, Chiba, Japan

    3 shared publications
  • Chie Kurokawa

    Department of Radiation Oncology, Faculty of Medicine, Juntendo University

    2 shared publications
  • Jun Takatsu

    Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Kazunori Nitta

    Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, Kamakura, Kanagawa, 247-8533, JAPAN

    2 shared publications

Latest Publications

  • Open Access

    Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in 177Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial

    by Takayuki Yagihashi, Kenta Miwa, Noriaki Miyaji, Satoru Sugimoto, Hideki Hayakawa, Noritoshi Kobayashi, Shoko Takano, Taro Murai

    Background: Targeted radiopharmaceutical therapy (TRT) offers a promising approach for cancer treatment by delivering radiation directly to tumor cells while sparing healthy tissues. Accurate dosimetry of organs and tumors is crucial to optimize therapeutic efficacy and minimize toxicity, particularly for dose-limiting organs such as the kidneys. Although routine dosimetry using single-photon emission computed tomography (SPECT) is recommended per guidelines, its widespread clinical application remains limited owing to a lack of consensus on the optimal frequency and timing of SPECT scans for accurate dosimetry, which leads to variability in clinical practice and hinders robust dose–response relationships. Furthermore, absorbed dose calculations rely on software-specific curve-fitting models. Thus, discrepancies in dose estimates among different simulation software programs pose a significant challenge to standardizing dosimetry workflows. Objective: We aimed to explore the optimal SPECT imaging schedule, evaluate differences among simulation software programs, and establish a standardized protocol for future epidemiological research to define organ tolerance doses and facilitate wider adoption of personalized TRT regimens. Methods: This exploratory observational trial will determine the optimal SPECT imaging protocol and consistency of dosimetry estimates using software programs for Lu-177-DOTATATE therapy in patients with neuroendocrine tumors. In a single treatment cycle, SPECT imaging will be performed at 4, 24, 96, and 168 hours following Lu-177-DOTATATE administration. The true absorbed dose cannot be directly measured; therefore, doses calculated using all time points (the 4-point method) for each patient will be used as the reference standard and compared with estimates derived from 1- to 3-point methods. Consequently, 15 dose simulations will be conducted per patient. This study implements a 5+5 design (rule-based design). The primary endpoint is the incidence of dose errors for each patient across different dose-calculation software systems. The kidney absorbed dose will be the primary focus of evaluation, with secondary analyses including tumor and other organ dosimetry. In principle, a dose error of <5% will be considered acceptable in each software system, depending on the absolute dose level. Differences among software systems and between patients will be evaluated using descriptive statistical methods. The study was approved by the Tokushukai Group Ethics Committee (Approval No. 2447). Results: Recruitment began on March 5, 2024, and 4 participants have been enrolled as of September 2025. Data collection is expected to be completed by February 2027, with the study results anticipated in August 2027. Conclusions: This study will evaluate whether simplified SPECT imaging protocols can maintain dosimetric accuracy while reducing the burden on patients and providers. It will also compare absorbed dose estimates across software programs to assess consistency and reliability as a reference. Findings will be disseminated through open-access peer-reviewed journals and relevant conferences and events.

  • Improved stoichiometric model for megavoltage computed tomography number conversion and dose calculation within the TomoTherapy delivery system

    by Shogo Tsunemine, Shuichi Ozawa, Minoru Nakao, Hideharu Miura, Takashi Onishi, Mamoru Ichiki, Satoru Sugimoto, Tatsuya Inoue, Yuya Oki, Hiroaki Akasaka, et al.

  • Evaluating optimal quality assurance and quality control conditions of activation measurements at the accelerator-based boron neutron capture therapy system employing a lithium target

    by Shunsuke Suzuki, Takayuki Yagihashi, Kazunori Nitta, Masashi Yamanaka, Naoki Sato, Shinichi Gotoh, Satoru Sugimoto, Shintaro Shiba, Hironori Nagata, Hiroki Tanaka

    Evaluating neutron output is important to ensure proper dose delivery for patients in boron neutron capture therapy (BNCT). It requires efficient quality assurance (QA) and quality control (QC) while maintaining measurement accuracy. This study investigated the optimal measurement conditions for QA/QC of activation measurements using a high-purity germanium (HP-Ge) detector in an accelerator-based boron neutron capture therapy (AB-BNCT) system employing a lithium target. The QA/QC uncertainty of the activation measurement was evaluated based on counts, reproducibility, and standard radiation source uncertainties. Measurements in a polymethyl methacrylate (PMMA) cylindrical phantom using aluminum-manganese (Al–Mn) foils and aluminum-gold (Al–Au) foils and measurements in a water phantom using gold wire with and without cadmium cover were performed to determine the optimal measurement conditions. The QA/QC uncertainties of the activation measurements were 4.5% for Au and 4.6% for Mn. The optimum irradiation proton charge and measurement time were determined to be 36 C and 900 s for measurements in a PMMA cylindrical phantom, 7.0 C and 900 s for gold wire measurements in a water phantom, and 54 C and 900 s at 0–2.2 cm depth and 3,600 s at deeper depths for gold wire measurements with cadmium cover. Our results serve as a reference for determining measurement conditions when performing QA/QC of activation measurements using HP-Ge detectors at an AB-BNCT employing a lithium target.


  • Dose Calculation Algorithm

    by Satoru Sugimoto, Tatsuya Inoue, Jun Takatsu

  • Open Access

    Dosimetric investigation of whole-brain radiotherapy with helical intensity modulated radiation therapy and volumetric modulated arc therapy for scalp sparing

    by Ryosuke Shirata, Tatsuya Inoue, Satoru Sugimoto, Anneyuko I Saito, Motoko Omura, Yumiko Minagawa, Keisuke Sasai

    Objective: Intensity-modulated radiotherapy (IMRT) is a well-established radiotherapy technique for delivering radiation to cancer with high conformity while sparing the surrounding normal tissue. Two main purposes of this study are: (1) to investigate dose calculation accuracy of helical IMRT (HIMRT) and volumetric-modulated arc therapy (VMAT) on surface region and (2) to evaluate the dosimetric efficacy of HIMRT and VMAT for scalp-sparing in whole brain radiotherapy (WBRT). Methods: First, using a radiochromic film and water-equivalent phantom with three types of boluses (1, 3, 5 mm), calculation/measurement dose agreement at the surface region in the VMAT and HIMRT plans were examined. Then, HIMRT, 6MV-VMAT and 10MV-VMAT with scalp-sparing, and two conventional three-dimensional conformal radiotherapy plans (6MV-3DCRT and 10MV-3DCRT; as reference data) were created for 30 patients with brain metastasis (30 Gy/10 fractions). The mean dose to the scalp and the scalp volume receiving 24 and 30 Gy were compared. Results: The percentage dose differences between the calculation and measurement were within 7%, except for the HIMRT plan at a depth of 1 mm. The averaged mean scalp doses [Gy], V24Gy [%], and V30Gy [%] (1SD) for 6MV-3DCRT, 10MV-3DCRT, HIMRT, 6MV-VMAT, and 10MV-VMAT were [26.6 (1.1), 86.4 (7.3), 13.2 (4.2)], [25.4 (1.0), 77.8 (7.5), 13.2 (4.2)], [23.2 (1.5), 42.8 (19.2), 0.2 (0.5)], [23.6 (1.6), 47.5 (17.9), 1.2 (1.8)], and [22.7 (1.7), 36.4 (17.6), 0.7 (1.1)], respectively. Conclusion: Regarding the dose parameters, HIMRT achieved a lower scalp dose compared with 6MV-VMAT. However, the highest ability to reduce the mean scalp dose was showed in 10MV-VMAT. Advances in knowledge: Scalp-sparing WBRT using HIMRT or VMAT may prevent radiation-induced alopecia in patients with BM.


  • Open Access

    MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience

    by Yoichi Muramoto, Naoya Murakami, Tatsuki Karino, Satoru Sugimoto, Jun Takatsu, Masaki Oshima, Yasuo Kosugi, Terufumi Kawamoto, Takashi Hirayama, Kazunari Fujino, et al.


  • Intracranial stereotactic radiotherapy in off-isocenter target with SyncTraX FX4

    by Jun Tomihara, Jun Takatsu, Naoya Hara, Satoru Sugimoto, Naoto Shikama, Keisuke Sasai


  • Open Access

    Development and Evaluation of Jaw Position Detection Method in Jaw-tracking Delivery Using an Electronic Portal Imaging Device Cine Mode

    by Toru Kawabata, Satoru Sugimoto, Chie Kurokawa, Keisuke Usui, Tatsuya Inoue, Hironori Nagata, Hiroyuki Watanabe, Keisuke Sasai

    Objectives To develop a method for detecting jaw positions during jaw-tracking delivery to ensure an accurate delivery of radiation to patients using an electronic portal imaging device (EPID) in the cine mode on a linear accelerator for radiotherapy. Materials A bidirectional picket fence (BPF) plan was used in a novel application to detect jaw positions during jaw-tracking delivery. In the BPF plan, jaws tracked multileaf collimator (MLC) apertures. The irradiated patterns were acquired by an EPID in the cine mode. Methods The upper- and lower-half leaves in the MLC moved in opposite directions to facilitate detection of jaw positions on EPID images. A picket-fence-like image was created by summing all acquired cine images and evaluated to detect MLC leaf positions. Results Jaw positions determined on the cine images were compared with those expected from the delivered BPF plan. The absolute differences (average ± 1 standard deviation) were 0.16 ± 0.19 mm for the X1 jaw and 0.11 ± 0.16 mm for the X2 jaw. The maximum error in the MLC leaf positions detected in the picket-fence-like pattern were 0.11 mm. Conclusions Jaw positions during jaw-tracking delivery were identified using the cine EPID images and could be determined within an accuracy better than 0.5 mm. The BPF plan is also available as a picket fence test and can determine the MLC leaf positions to an accuracy better than 0.5 mm.

  • Investigation of clinical target volume segmentation for whole breast irradiation using three-dimensional convolutional neural networks with gradient-weighted class activation mapping

    by Megumi Oya, Satoru Sugimoto, Keisuke Sasai, Kazuhito Yokoyama

    This study aims to implement three-dimensional convolutional neural networks (3D-CNN) for clinical target volume (CTV) segmentation for whole breast irradiation and investigate the focus of 3D-CNNs during decision-making using gradient-weighted class activation mapping (Grad-CAM). A 3D-UNet CNN was adopted to conduct automatic segmentation of the CTV for breast cancer. The 3D-UNet was trained using three datasets of left-, right-, and both left- and right-sided breast cancer patients. Segmentation accuracy was evaluated using the Dice similarity coefficient (DSC). Grad-CAM was applied to trained CNNs. The DSCs for the datasets of the left-, right-, and both left- and right-sided breasts were on an average 0.88, 0.89, and 0.85, respectively. The Grad-CAM heatmaps showed that the 3D-UNet used for segmentation determined the CTV region from the target-side breast tissue and by referring to the opposite-side breast. Although the size of the dataset was limited, DSC ≥ 0.85 was achieved for the segmentation of breast CTV using the 3D-UNet. Grad-CAM indicates the applicable scope and limitations of using a CNN by indicating the focus of such networks during decision-making.